The blood pressure control effect of captopril sustained-release-tablets based combination antihypertensive therapy on hospitalized high-risk patients with hypertension in high altitude region / 中国综合临床
Clinical Medicine of China
; (12): 593-596, 2011.
Article
em Zh
| WPRIM
| ID: wpr-416334
Biblioteca responsável:
WPRO
ABSTRACT
Objective To investigate the blood pressure control effect of captopril sustained-releasetablets based combination, antihypertensive therapy on hospitalized high-risk patients with hypertension in high altitude region. Methods According to the blood pressure,risk factors and combined target organ damage,331 hospitalized patients with essential hypertension were divided into 2 groups and accepted different treatment:low-risk group had monotherapy (n=102) , and night-risk group had captopril sustained-release-tablets based combination antihypertensive therapy (n =229). The discharge blood pressure,extent of SBP/DBP decrease and the compliance rate of discharge blood pressure of two groups were compared. Results The extent of SBP/DBP decrease in hight-risk group was significantly greater than low-risk group (SBP [36. 83 ± 22. 23] mm Hg vs.[28. 74 ±18.71] mm Hg,t=-3. 207,P 0. 05;DBP[80. 67 ±9. 82]mm Hg vs. [78. 40 ±9. 97]mm Hg,t =-1.910,P > 0. 05). Furthermore we found no significant difference in the control rate of blood pressure between high-risk and low-risk group (72. 06% vs. 71. 57% , x2 = 0.928, P > 0. 05). Conclusion The captopril sustainedrelease-tablets based combination antihypertensive therapy is a reliable treatment in high-risk patients with hypertension from high altitude region,which shows satisfying blood pressure control rate.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Idioma:
Zh
Revista:
Clinical Medicine of China
Ano de publicação:
2011
Tipo de documento:
Article